Timeliness of a potential automated system for national surveillance of healthcare-associated infections in England
Quan TP. et al, (2025), Journal of Hospital Infection, 161, 10 - 12
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories
Zwerwer LR. et al, (2025), Nature Communications, 16
Machine learning and clinician predictions of antibiotic resistance in Enterobacterales bloodstream infections
Yuan K. et al, (2025), Journal of Infection, 90, 106388 - 106388
The impact of antimicrobial stewardship ward rounds on antimicrobial use and predictors of advice, uptake, and outcomes
Eyre DW. et al, (2025), Journal of Infection, 90, 106419 - 106419
Addition of Macrolide Antibiotics for Hospital Treatment of Community-Acquired Pneumonia
Wei J. et al, (2024), The Journal of Infectious Diseases
Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar
Pritchard E. et al, (2024), American Journal of Epidemiology, 193, 1848 - 1860
Corrigendum to “No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia” [J Infect 88 (2024) 106161]
Wei J. et al, (2024), Journal of Infection, 89, 106361 - 106361
Predicting individual patient and hospital-level discharge using machine learning
Wei J. et al, (2024), Communications Medicine, 4
Comparison of direct cDNA and PCR-cDNA Nanopore sequencing of RNA from Escherichia coli isolates
Rodger G. et al, (2024), Microbial Genomics, 10
Predicting future hospital antimicrobial resistance prevalence using machine learning
Vihta K-D. et al, (2024), Communications Medicine, 4
Expanding the use of mathematical modeling in healthcare epidemiology and infection prevention and control.
Grant R. et al, (2024), Infection control and hospital epidemiology, 1 - 6
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
Naghavi M. et al, (2024), The Lancet, 404, 1199 - 1226
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators None., (2024), The Lancet. Infectious diseases, 24, 974 - 1002
'Bloodstream infection': A valuable concept we should keep in our toolbox.
Danielsen AS. et al, (2024), The Journal of infection, 89
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
Lim YJ. et al, (2024), British journal of haematology, 205, 440 - 451
Retrospective analysis of hospital electronic health records reveals unseen cases of acute hepatitis with unknown aetiology in adults in Oxfordshire
Tan CCS. et al, (2024), BMC Public Health, 24
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022–23
Cane J. et al, (2024), Journal of Infection, 88, 106164 - 106164
The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization.
Unemo M. et al, (2024), The Journal of antimicrobial chemotherapy
Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection
Gu Q. et al, (2024), Journal of Infection, 88, 106156 - 106156
Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection.
Gu Q. et al, (2024), The Journal of infection
Target enrichment improves culture-independent detection of Neisseria gonorrhoeae and antimicrobial resistance determinants direct from clinical samples with Nanopore sequencing
Street TL. et al, (2024), Microbial Genomics, 10
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework.
AMR-X Collaborators None., (2024), The Lancet. Microbe
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis
Sartorius B. et al, (2024), The Lancet Global Health, 12, e201 - e216
Comparison of direct cDNA and PCR-cDNA Nanopore sequencing ofEscherichia coliisolates
Rodger G. et al, (2024)
Genomic epidemiology of Candida auris introduction and outbreaks in the United Kingdom
Kappel D. et al, (2024)
Changes in the investigation and management of suspected myocardial infarction and injury during COVID-19: a multi-centre study using routinely collected healthcare data.
Chammas L. et al, (2024), Frontiers in cardiovascular medicine, 11
Infectious disease surveillance needs for the United States: lessons from Covid-19.
Lipsitch M. et al, (2024), Frontiers in public health, 12
Predicting future hospital antimicrobial resistance prevalence using machine learning
Vihta K-D. et al, (2023)
The burden and dynamics of hospital-acquired SARS-CoV-2 in England
Cooper BS. et al, (2023), Nature, 623, 132 - 138
Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology
Perkmann T. et al, (2023), Journal of Clinical Pathology, 76, 770 - 777
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.
Bešević J. et al, (2023), Journal of epidemiology and community health
The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008-2018: expanding surveillance using existing laboratory and register data.
Danielsen AS. et al, (2023), European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis
Aguilar GR. et al, (2023), The Lancet Regional Health - Americas, 25, 100561 - 100561
Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
Eyre DW. et al, (2023), The Lancet. Infectious diseases, 23, 922 - 932